RS
Rekha Sushil Maurya
About Rekha Sushil Maurya
Data last updated:
Rekha Sushil Maurya is a Director at Suvi Pharma Private Limited (since 2016) and Designated Partner at Ayucta Laboratories Llp (since 2021). The companies operate in Service and Chemicals. The largest current company by reported revenue is Suvi Pharma Private Limited at ₹31.1 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Suvi Pharma Private Limited U93000MH2016PTC287224 | Director | 28 Oct 2016 | 2016 | ₹31.1 Lakh (FY 2024) | Active |
| Ayucta Laboratories Llp AAX-6423 | Designated Partner | 05 Jul 2021 | 2021 | Active |
Board colleagues of Rekha Sushil Maurya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sushilkumar Ramraj Maurya | 07634725 | Suvi Pharma Private Limited , Ayucta Laboratories Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rekha Sushil Maurya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rekha Sushil Maurya
Rekha Sushil Maurya currently holds 2 directorships: Suvi Pharma Private Limited (Director, since 28 Oct 2016, revenue ₹31.1 Lakh (FY 2024)); Ayucta Laboratories Llp (Designated Partner, since 05 Jul 2021).
Rekha Sushil Maurya was first appointed on 28 Oct 2016 as Director at Suvi Pharma Private Limited. The most recent appointment on record is 05 Jul 2021 at Ayucta Laboratories Llp.
The current boards of Rekha Sushil Maurya's companies include Sushilkumar Ramraj Maurya (Suvi Pharma Private Limited).